Clinical trial

Phase II Prospective Monocentric Study on Prostate Cancer Restaging by Using PET/MR With Innovative Radiotracers

Name
PCa Restaging- PET/MR
Description
The overall goal is to provide an innovative approach to restage patients with biochemical recurrence of prostate cancer by using hybrid PET/MR with innovative radiotracers (68Ga-PSMA and 68Ga-RM2)
Trial arms
Trial start
2020-06-03
Estimated PCD
2022-10-05
Trial end
2022-10-05
Status
Completed
Phase
Early phase I
Treatment
68Ga-PSMA
Glu-NH-CO-NH-Lys-(Ahx)-\[68Ga(HBED-CC)\] (68Ga-PSMA)
Arms:
Dual tracer PET/MRI
68Ga-RM2
Bombesin receptor antagonist (68Ga-RM2)
Arms:
Dual tracer PET/MRI
Size
60
Primary endpoint
To evaluate the diagnostic accuracy of 68Ga-PSMA PET/MR to identify the site of recurrence in patients with biochemical relapse of PCa after primary treatment and comparison with the performances of 68Ga-RM2 PET/MR
Imaging will be performed at T0 and T1 (at least 2 days apart). PET/MR results will be compared to other imaging procedures performed in the course of routinely work-up evaluation.
Eligibility criteria
Inclusion Criteria: * Patients with histological proven diagnosis of prostate cancer. * Patients treated with radical therapy (RP o EBRT, with or without further adjuvant therapies), who present rising serum PSA values ≥ 0.2 ng/mL. * Age ≥ 18 years-old. * Willing to provide a signed informed consent. Exclusion Criteria: * Age \< 18 years-old. * Previous and/or concomitant androgen deprivation therapy will be excluded. * Any additional medical condition that may significantly interfere with study compliance. * Contraindications to MR study (i.e. Pacemaker
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE2'], 'designInfo': {'allocation': 'NA', 'interventionModel': 'SINGLE_GROUP', 'primaryPurpose': 'DIAGNOSTIC', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 60, 'type': 'ACTUAL'}}
Updated at
2023-04-10

1 organization

1 product

1 drug

1 indication

Organization
IRCCS San Raffaele
Indication
Prostate Cancer
Product
68Ga-RM2